Search

Your search keyword '"Shah Alpesh"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Shah Alpesh" Remove constraint Author: "Shah Alpesh"
233 results on '"Shah Alpesh"'

Search Results

1. Corneal Endothelial Safety of Intracameral Preservative-free 1% Xylocaine

2. Management of congenital bilateral subluxated cataract with Cionni ring

8. Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results From the RESOLUTE ONYX Postapproval Study

9. List of contributors

13. Impacto de la adherencia a un algoritmo híbrido para la selección de la estrategia inicial de cruce en la intervención coronaria percutánea de oclusiones crónicas

15. P170: Safety and Tolerability of Brexpiprazole for the Treatment of Agitation in Alzheimer’s Dementia: Pooled Results From Three Phase III Trials

19. Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results from RESOLUTE ONYX Postapproval Study

20. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System

21. Abstract 16435: Contemporary In-Hospital Outcomes of Chronic Total Occlusion Interventions: Update From the PROGRESS-CTO (prospective Global Registry for the Study of Chronic Total Occlusion Intervention) Multicenter International Registry

22. B-16 | The RESOLUTE ONYX Bifurcation Study: 3-Year Outcomes in Patients With Coronary Bifurcation Lesions

23. Supplementary Tables 1-6 from ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

24. Supplementary Figures 1-7 from ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

25. Data from ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

26. Supplementary Methods from ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

27. Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis

30. IMPROVEMENT IN LEFT VENTRICULAR EJECTION FRACTION AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH CHRONIC TOTAL OCCLUSION: A SINGLE CENTER STUDY EVALUATING CARDIOVASCULAR OUTCOMES

31. Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry

36. Guidewire and microcatheter utilization patterns during antegrade wire escalation in chronic total occlusion percutaneous coronary intervention: Insights from a contemporary multicenter registry

37. B-25 | Two-Year Outcomes in Patients with Bifurcation Lesions treated with Resolute ONYX ZES: Final Results from the RESOLUTE ONYX Bifurcation Study

Catalog

Books, media, physical & digital resources